Literature DB >> 10884447

Chlamydia pneumoniae and the risk of first ischemic stroke : The Northern Manhattan Stroke Study.

M S Elkind1, I F Lin, J T Grayston, R L Sacco.   

Abstract

BACKGROUND AND
PURPOSE: Serological evidence of infection with Chlamydia pneumoniae has been associated with cardiovascular disease in multiple epidemiological studies. The data on its association with ischemic stroke are limited. We sought to determine whether chronic C pneumoniae infection is associated with ischemic stroke in a multi-ethnic population.
METHODS: The Northern Manhattan Stroke Study contains a population-based, case-control study component. Cases had first ischemic stroke and matched control subjects were derived through random digit dialing. Titers of IgG, IgA, and IgM antibodies specific for C pneumoniae were measured with the use of microimmunofluorescence, and titers >/=1:16 were considered positive. Conditional logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (95% CIs) after adjustment for medical, behavioral, and socioeconomic factors.
RESULTS: Eighty-nine cases and 89 control subjects were selected. Mean age among cases was 68.5+/-12.8 years; 53% were women and 15% of the subjects were white, 28% were black, and 54% were Hispanic. Elevated C pneumoniae IgA titers were significantly associated with risk of ischemic stroke after adjusting for other stroke risk factors (adjusted OR 4. 51, 95% CI 1.44 to 14.06). IgG titers were less strongly associated with stroke risk (adjusted OR 2.59, 95% CI 0.87 to 7.75). The association of IgA with stroke risk was detected in both younger and older groups, in men and women, and in whites, blacks, and Hispanics. There was also a significant continuous increase in risk associated with the log-transformation of the titer for IgA (adjusted OR 1.32, 95% CI 1.05 to 1.66) but not IgG.
CONCLUSIONS: Serological evidence of chronic infection with C pneumoniae is associated with risk of ischemic stroke in an urban, multi-ethnic population. IgA titers may be a better marker of this risk than are IgG titers. This association is independent of other vascular disease risk factors. Further prospective epidemiological studies of the effect of this infection on stroke risk are warranted.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10884447     DOI: 10.1161/01.str.31.7.1521

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  31 in total

Review 1.  Role of infectious and immune factors in coronary and cerebrovascular arteriosclerosis.

Authors:  Claudia Stöllberger; Josef Finsterer
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

2.  Temporal expression of type III secretion genes of Chlamydia pneumoniae.

Authors:  Anatoly Slepenkin; Vladimir Motin; Luis M de la Maza; Ellena M Peterson
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

3.  Chlamydia pneumoniae seropositivity and risk of ischemic stroke: a nested case-control study.

Authors:  Søren P Johnsen; Kim Overvad; Lars Ostergaard; Anne Tjønneland; Steen E Husted; Henrik T Sørensen
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 4.  Inflammatory mechanisms of stroke.

Authors:  Mitchell S V Elkind
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

5.  Giant cell arteritis and cardiovascular disease in older adults.

Authors:  J G Ray; M M Mamdani; W H Geerts
Journal:  Heart       Date:  2005-03       Impact factor: 5.994

6.  Chlamydophila pneumoniae Infection and Its Role in Neurological Disorders.

Authors:  Carlo Contini; Silva Seraceni; Rosario Cultrera; Massimiliano Castellazzi; Enrico Granieri; Enrico Fainardi
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-02-21

7.  Association between Chlamydia pneumoniae IgG antibodies and migraine.

Authors:  QiHong Lu; Jinzh Xu; HongYan Liu
Journal:  J Headache Pain       Date:  2009-02-24       Impact factor: 7.277

8.  Infectious burden and risk of stroke: the northern Manhattan study.

Authors:  Mitchell S V Elkind; Pankajavalli Ramakrishnan; Yeseon P Moon; Bernadette Boden-Albala; Khin M Liu; Steve L Spitalnik; Tanja Rundek; Ralph L Sacco; Myunghee C Paik
Journal:  Arch Neurol       Date:  2009-11-09

9.  Infectious burden and cognitive function: the Northern Manhattan Study.

Authors:  Mira Katan; Yeseon Park Moon; Myunghee Cho Paik; Ralph L Sacco; Clinton B Wright; Mitchell S V Elkind
Journal:  Neurology       Date:  2013-03-26       Impact factor: 9.910

10.  Infectious Burden and Cognitive Decline in the Northern Manhattan Study.

Authors:  Clinton B Wright; Hannah Gardener; Chuanhui Dong; Mitsuhiro Yoshita; Charles DeCarli; Ralph L Sacco; Yaakov Stern; Mitchell S V Elkind
Journal:  J Am Geriatr Soc       Date:  2015-08       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.